Supplementary Figure S2 from HBV Reactivation in Patients with Hepatocellular Carcinoma Treated with PD-1/-L1 Antibodies and Concurrent Antiviral Prophylaxis Agents: A Prospective Observational Study

ZeFeng Du; ZhiCheng Lai; YeXing Huang; Hailong Chen; Ping Ma; QiJiong Li; Wei Wei; Yaojun Zhang; MinShan Chen; Binkui Li; Li Xu; Ming Shi; Anna Kan; MinKe He

doi:10.1158/1078-0432.31353215

Supplementary Figure S2 from HBV Reactivation in Patients with Hepatocellular Carcinoma Treated with PD-1/-L1 Antibodies and Concurrent Antiviral Prophylaxis Agents: A Prospective Observational Study

2026 Open access

Read full text

Authors: ZeFeng Du, ZhiCheng Lai, YeXing Huang, Hailong Chen, Ping Ma, QiJiong Li, Wei Wei, Yaojun Zhang, MinShan Chen, Binkui Li, Li Xu, Ming Shi

+2 more

Anna Kan, MinKe He

DOI: 10.1158/1078-0432.31353215

Cited by: 0

Abstract

Supplementary Figure 2. Survival analysis. Kaplan‒Meier curves of overall survival of patients in HBV DNA-low and HBV DNA-high groups, using (A) 1000 IU/mL and (B) 2000 IU/mL as cutoff, respectively.

Fields of Study & Subjects

Hepatitis B Virus Studies Hepatocellular Carcinoma Treatment and Prognosis Cancer Immunotherapy and Biomarkers

Publication details

Publication date: 17 February 2026
Language: EN